Association of cystatin C with adverse outcomes.
Association of cystatin C with adverse outcomes.
复制标题
DOI:
10.1097/mnh.0b013e328326f3dd
复制
发表时间:
2009-05
影响因子:
3.2
通讯作者:
Sarnak MJ
中科院分区:
文献类型:
--
作者:
Madero M;Sarnak MJ
To discuss recent studies which have evaluated determinants of cystatin C and to focus on the relationship of cystatin C with mortality, cardiovascular disease (CVD) and non-cardiovascular outcomes. In the Chronic Kidney Disease Epidemiology Study cystatin C was associated with demographic characteristics independent of measured glomerular filtration rate (GFR), although this was to a smaller extent than creatinine. In patients with established CKD, cystatin C was strongly and inversely correlated with measured GFR, suggesting that although cystatin C may have other determinants, it is primarily a measure of kidney function. Several cohort studies, particularly in older adults, have now demonstrated that cystatin C is linearly associated with mortality, CVD and non-CVD outcomes, whereas creatinine is primarily associated with risk in individuals with more advanced kidney disease. A recent study has also shown that changes in kidney function as ascertained by cystatin C, even within the relatively normal range, are associated with subsequent CVD and all-cause mortality among older adults. Cystatin C appears to capture an association of mild kidney disease with increased risk of mortality, CVD and non-CVD outcomes. Future studies should evaluate whether cystatin C can improve medical decision-making and lead to favorable patient outcomes.
登录
查看更多内容
影响因子:
13.2
作者:
Koettgen, Anna;Selvin, Elizabeth;Coresh, Josef
通讯作者:
Coresh, Josef
影响因子:
5.3
作者:
Arpegard, J.;Oestergren, J.;Svensson, P.
通讯作者:
Svensson, P.
影响因子:
5.9
作者:
Muntner, Paul;Winston, Jonathan;Fox, Caroline S.
通讯作者:
Fox, Caroline S.
影响因子:
30.8
作者:
Kaeser, Stephan A.;Herzig, Martin C.;Jucker, Mathias
通讯作者:
Jucker, Mathias
影响因子:
5.4
作者:
Manetti, L;Pardini, E;Martino, E
通讯作者:
Martino, E